Citation Impact Factors

Writing in the Sept. 14, 1998, issue of The Scientist ("The Under-reporting of Research Impact," 12[18]:9), Ronald N. Kostoff outlines steps to better utilize the Science Citation Index® (SCI) to track research impact. Kostoff states that the cooperation of scientific journals would be needed to ensure the completeness and adequacy of reference lists, as well as to assess whether bibliographies are properly prioritized with respect to the relative importance of each reference. I believe thi

Written byDavid Watson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Writing in the Sept. 14, 1998, issue of The Scientist ("The Under-reporting of Research Impact," 12[18]:9), Ronald N. Kostoff outlines steps to better utilize the Science Citation Index® (SCI) to track research impact. Kostoff states that the cooperation of scientific journals would be needed to ensure the completeness and adequacy of reference lists, as well as to assess whether bibliographies are properly prioritized with respect to the relative importance of each reference. I believe this is unlikely to occur for a variety of reasons, including:

In summary, while I do agree that impact factors are a good choice as a quantifiable metric for research assessment, it is my opinion that using an upgraded version of the SCI as a means to measure research impact through enhanced referencing of journals, faces at best an uphill battle.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies